미국의 의료 전용 체어 시장 규모, 점유율, 동향 분석 리포트, 제품별, 부문 예측(2024-2030년)

U.S. Specialty Medical Chairs Market Growth & Trends:

The U.S. specialty medical chairs market size is anticipated to reach USD 2.68 billion by 2030, expanding at a CAGR of 6.9% from 2024 to 2030, according to a new report by Grand View Research, Inc. As the global population continues to age, the demand for these specialty medical chairs and other assistive devices increases. The elderly population often experience age-related health issues, such as arthritis, back pain, and weakened muscles, which can be alleviated by using specialized medical chairs.

With the increasing population of elderly people, there is a surge in the demand for healthcare services and infrastructure to address the unique & evolving healthcare needs of the elderly. According to the WHO data, in 2022, one out of every six people worldwide will be 60 years or older by the year 2030. Moreover, the number of Americans aged 65 and older is projected to increase from 58 million in 2022 to 82 million by 2050. This, in turn, is estimated to propel the demand for specialty medical chairs over the forecast period.

Many governments and insurance providers recognize the importance of medical chairs for the elderly and are implementing initiatives to make these products more accessible and affordable.

U.S. Specialty Medical Chairs Market Report Highlights:

• Rehabilitation chairs dominated the product segment with more than 40% share in 2023 owing to the customizable features it offers
• The treatment chairs segment is expected to grow at the fastest CAGR over the forecast period
• The increasing aging population and increasing incidences of orthopedic disorders are contributing to the growing demand for specialty medical chairs
• Market players operating in U.S. specialty medical chairs market include ActiveAid, Inc., DentalEZ, Inc., Fresenius Medical Care AG & Co. KGaA, Topcon Corp., Midmark Corp., Danaher (KaVo Dental GmbH), Dentsply Sirona, Planmeca Oy, Hill Laboratories Company

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Volume price analysis (Model 2)
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Specialty Medical Chairs Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
• 3.3. U.S. Specialty Medical Chairs Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. U.S. Specialty Medical Chairs Market: Product Estimates & Trend Analysis

• 4.1. Product Market Share, 2023 & 2030
• 4.2. Segment Dashboard
• 4.3. U.S. Specialty Medical Chairs by Product Outlook
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
  • 4.4.1. Examination Chairs
    • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.2. Rehabilitation Chairs
    • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.3. Treatment Chairs
    • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3.2. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Competitive Landscape

• 5.1. Recent Developments & Impact Analysis, By Key Market Participants
• 5.2. Company/Competition Categorization
• 5.3. Vendor Landscape
  • 5.3.1. List of key distributors and channel partners
  • 5.3.2. Key customers
  • 5.3.3. Key company heat map analysis, 2023
• 5.4. Company Profiles
  • 5.4.1. A-dec, Inc.
    • 5.4.1.1. Company overview
    • 5.4.1.2. Financial performance
    • 5.4.1.3. Product benchmarking
    • 5.4.1.4. Strategic initiatives
  • 5.4.2. ActivAid, Inc.
    • 5.4.2.1. Company overview
    • 5.4.2.2. Financial performance
    • 5.4.2.3. Product benchmarking
    • 5.4.2.4. Strategic initiatives
  • 5.4.3. DentalEZ, Inc.
    • 5.4.3.1. Company overview
    • 5.4.3.2. Financial performance
    • 5.4.3.3. Product benchmarking
    • 5.4.3.4. Strategic initiatives
  • 5.4.4. Fresenius Medical Care AG & Co. KGaA
    • 5.4.4.1. Company overview
    • 5.4.4.2. Financial performance
    • 5.4.4.3. Product benchmarking
    • 5.4.4.4. Strategic initiatives
  • 5.4.5. Topcon Corp.
    • 5.4.5.1. Company overview
    • 5.4.5.2. Financial performance
    • 5.4.5.3. Product benchmarking
    • 5.4.5.4. Strategic initiatives
  • 5.4.6. MidMark Corp.
    • 5.4.6.1. Company overview
    • 5.4.6.2. Financial performance
    • 5.4.6.3. Product benchmarking
    • 5.4.6.4. Strategic initiatives
  • 5.4.7. Danaher
    • 5.4.7.1. Company overview
    • 5.4.7.2. Financial performance
    • 5.4.7.3. Product benchmarking
    • 5.4.7.4. Strategic initiatives
  • 5.4.8. Dentsply Sirona
    • 5.4.8.1. Company overview
    • 5.4.8.2. Financial performance
    • 5.4.8.3. Product benchmarking
    • 5.4.8.4. Strategic initiatives
  • 5.4.9. Planmeca Oy
    • 5.4.9.1. Company overview
    • 5.4.9.2. Financial performance
    • 5.4.9.3. Product benchmarking
    • 5.4.9.4. Strategic initiatives
  • 5.4.10. Hill Laboratories Company
    • 5.4.10.1. Company overview
    • 5.4.10.2. Financial performance
    • 5.4.10.3. Product benchmarking
    • 5.4.10.4. Strategic initiatives